Blue Water Angels
VC Fund
Midland, United States
Blue Water Angels is a VC fund in Midland focused on Biotechnology and SaaS. BlueWater Angels is a network of more than 30 high-net-worth individuals and select organizations interested in investing capital in promising companies.While return on investment (ROI) is their primary goal, they also highly value supporting the entrepreneurial community for the economic benefit of the entire mid-Michigan region and the state.In its first year, BlueWater Angels received funding requests from over 100 companies, reviewed nearly 40 in detail, heard presentations from a dozen companies, and closed its first investment in a mid-Michigan-based advanced materials company. The amount of investment capital available for annual investments now tops $1.4 million and is only expected to grow.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries Blue Water Angels invests in
Stages Blue Water Angels invests in
Countries Blue Water Angels invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jim Plonka
|
|||
|
John Bartos
|
|||
Ken Kousky
|
|||
|
Paul Murray
|
|||
Investment Focus
Industry
- Biotechnology 3 (33%)
- SaaS 1 (11%)
- Solar 1 (11%)
- Energy 1 (11%)
- Battery 1 (11%)
Stage
- Seed 2 (22%)
- Series A 2 (22%)
- Series B 1 (11%)
- Debt Financing 1 (11%)
- Convertible Note 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jim Plonka
Director
|
Director | Total investments: 0 | Find email | |
|
John Bartos
Secretary
|
Secretary | Total investments: 0 | Find email | |
|
Ken Kousky
Co-founder, President & Chairman
|
Co-founder, President & Chairman | Total investments: 3 | Find email | |
|
Paul Murray
Treasurer
|
Treasurer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
GreenMark Biomedical
|
GreenMark is a healthcare company providing health-based benefits using nanoparticles. The company develops technologies that involve biopolymer nanoparticles produced from natural starch as a raw material. | $830K / Convertible Note / Jan 26, 2022 | |
|
GreenMark Biomedical
|
GreenMark is a healthcare company providing health-based benefits using nanoparticles. The company develops technologies that involve biopolymer nanoparticles produced from natural starch as a raw material. | $830K / Convertible Note / Jan 26, 2022 | |
Opus Genetics(formerly Ocuphire Pharma)
|
Ocuphire Pharma is a clinical-stage biopharmaceutical company focuses on the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders. It is currently focused on providing a novel once-daily eye drop treatment option, Nyxol, to treat multiple front-of-the-eye disorders, including night visiondisturbances, glaucoma, pharmacologically-induced mydriasis, and presbyopia. Nyxol eye drops are an investigational 505(b)(2) drug candidate in late-stage clinical development with over a decade of safety and efficacy data from Phase 1 and 2 trials. Part of their strategy is to explore opportunities to acquire additional ophthalmic assets for both the front and the back of the eyes and to seek strategic partners for global commercialization.The company was founded in 2018 and is headquartered in Farmington Hills, Michigan. | $5M / Seed / Jul 22, 2019 | |
|
GreenMark Biomedical
|
GreenMark is a healthcare company providing health-based benefits using nanoparticles. The company develops technologies that involve biopolymer nanoparticles produced from natural starch as a raw material. | $670K / Seed / Mar 20, 2019 | |
|
GreenMark Biomedical
|
GreenMark is a healthcare company providing health-based benefits using nanoparticles. The company develops technologies that involve biopolymer nanoparticles produced from natural starch as a raw material. | $500K / Seed / Jun 29, 2018 | |
RetroSense Therapeutics
|
RetroSense Therapeutics is a biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to retinitis pigmentosa (RP) and advanced dry age-related macular degeneration (advanced dry-AMD). There are currently no FDA approved drugs to improve or restore vision in patients withthese retinal degenerative conditions. The company's approach to using optogenetics in vision restoration is based on pioneering, proprietary research conducted at Wayne State University and Massachusetts General Hospital.Founded in 2009, RetroSense Therapeutics is headquartered in Ann Arbor, Michigan. | $6M / Series B / Nov 12, 2015 | |
GreenLancer
|
GreenLancer is the only online marketplace to get standardized, quality design and engineering solutions with speed, scale and reliability.The platform allows for batch project management, in-app communication, and a team of support specialists to help businesses save time and money on solar, EV charging, and telecom solutions. Since 2013,GreenLancer has served more than 5,000 solar installers on over 150,000 projects, and deployed $1.8 billion (and counting) in commercial and residential solar nationwide. | $500K / Series A / Jul 11, 2013 | |
Advanced Battery Concepts
|
Advanced Battery Concepts is a battery technology development company focused on making better batteries. The company designs and develops bipolar lead-acid batteries. It serves military, industrial, stationary, renewable, automotive, and motive markets.Advanced Battery Concepts was formerly known as Advanced Battery Concepts Michigan and changedits name to Advanced Battery Concepts in March 2011. The company was founded in 2008 and is based in Clare, Michigan. | $1.2M / Debt Financing / Jan 08, 2013 | |
Instore
|
Instore provides a cloud-based POS platform for local merchants, including restaurants, cafes, and coffee shops.The Instore platform starts at the point-of-sale, then extends into people, menu, and customer management. Merchants use Instore to run their businesses more intelligently and cost-efficiently. As the world's first open POSplatform, Instore allows merchants to integrate 3rd party services, including payments, online ordering, loyalty, social media, and accounting, to name a few. | Series A / Oct 25, 2011 |
Co-Investors
Biosciences Research and Commercialization Center (BRCC)
3 deals together
Red Cedar Ventures
3 deals together
Michigan Rise
2 deals together
Northern Michigan Angels
2 deals together
Ann Arbor Angels
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Blue Water Angels invest in?
Blue Water Angels invests primarily in Biotechnology, SaaS and Solar startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Blue Water Angels?
Public channels for Blue Water Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Blue Water Angels?
The team at Blue Water Angels includes Jim Plonka (Director), John Bartos (Secretary) and Ken Kousky (Co-founder, President & Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
